SMAD7 and inflammatory bowel disease: Compared to the huge advances in new therapies for inflammation in IBD (anti-TNFs, anti-integrins, antisense to smad7, and kinase inhibitors), there has been no progress on therapeutic modalities that might prevent or reverse fibrosis in CD patients.